News in the Life Sciences Industry

STOCKHOLM, Jan. 3, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS) today announced that it has entered into a partnership with HealthLink Europe & International to serve as IRRAS' global logistics and customer service partner. Through this partnership, the companies will... Read more ››

STOCKHOLM, Jan. 3, 2019 /PRNewswire/ -- "Jan's executive industrial experience as head of R&D at two major pharmaceutical companies, and his involvement the discovery, development and approval of more than 20 products makes his experience and competence invaluable to Betagenon. As a member... Read more ››

GOTHENBURG, Sweden, Jan. 2, 2019 /PRNewswire/ --

STOCKHOLM, Jan. 2, 2019 /PRNewswire/ --

UPPSALA, Sweden, Jan. 2, 2019 /PRNewswire/ -- Biotage AB (Biotage), (Nasdaq Stockholm: BIOT.ST) - for the upcoming Annual General Meeting 2019 in Biotage AB, the Nomination Committee today publishes its proposal that the current CEO Torben Jørgensen shall be elected as a new board member. Proposals... Read more ››

STOCKHOLM, Dec. 28, 2018 /PRNewswire/ --

STOCKHOLM, Dec. 28, 2018 /PRNewswire/ -- The Supreme Administrative Court announced its judgment today in Essity's dispute with the Swedish Tax Agency regarding the agency's decision to impose additional taxes and tax surcharges for the years 2008 to 2012. As earlier announced by the company... Read more ››

STOCKHOLM, Dec. 28, 2018 /PRNewswire/ -- According to Essity's articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated... Read more ››

STOCKHOLM, Dec. 28, 2018 /PRNewswire/ --

STOCKHOLM, Dec. 28, 2018 /PRNewswire/ -- Institut de Cancérologie de Bourgogne has chosen RayStation as their sole treatment planning system (TPS). The group consists of three centers, placed in Auxerre, Dijon and Chalon-sur-Saône.

STOCKHOLM, Dec. 27, 2018 /PRNewswire/ --

STOCKHOLM, Dec. 21, 2018 /PRNewswire/ --

TOKYO, Dec. 21, 2018 /PRNewswire/ -- Mundipharma has submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimazolam for general anesthesia in Japan.

STOCKHOLM, Dec. 21, 2018 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that the first patient in the phase ll part of the BPT-201 study of birinapant in combination with Keytruda® (pembrolizumab) has been dosed.